drugset / Trial / NCT00674752

A Polysomnographic Study Of Single-Dose Gabapentin In Transient Insomnia

NCT00674752

Phase 3 Completed 377 enrolled Viatris Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to assess the effect of gabapentin on polysomnographic assessments in transient insomnia induced by a sleep phase advance.

Timeline

Start
2006-03
Primary completion
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 250 mg Oral
Subject Gabapentin Small molecule 500 mg Oral

Indications